Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage
Recruiting now · Not applicable
Conditions studied: Intraventricular Hemorrhage (IVH)
In brief
The purpose of this research study is to evaluate the safety and outcomes associated with the use of IRRAflow® System catheters in externally draining intracranial fluid to reduce intracranial pressure. This study will be comparing the IRRAflow® system to standard of care catheters used in the same procedure. The IRRAflow® system is FDA approved for this procedure.
Key facts
- Study ID
- NCT05970549
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 17
- Starts
- 2022-06-14
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-05-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >=18 years of age
- Intraventricular hemorrhage documented on head CT or MRI scan
- Need of cerebrospinal fluid drainage
- Indication for active treatment evaluated by the treating physicians
- Signed informed consent obtained by patient or Legal Authorized Representative
- Treatment possible within 72 hours of ictus
You may not qualify if…
- Patient has fixed and dilated pupils
- Pregnant or nursing women (fertile female participants will be required to take a validated pregnancy test for evaluation of pregnancy)
Where it is running
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.